Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease.

IMPORTANCE Recent large-scale genome-wide association studies have discovered several genetic variants associated with Alzheimer disease (AD); however, the extent to which DNA methylation in these AD loci contributes to the disease susceptibility remains unknown. OBJECTIVE To examine the association of brain DNA methylation in 28 reported AD loci with AD pathologies. DESIGN, SETTING, AND PARTICIPANTS Ongoing community-based clinical pathological cohort studies of aging and dementia (the Religious Orders Study and the Rush Memory and Aging Project) among 740 autopsied participants 66.0 to 108.3 years old. EXPOSURES DNA methylation levels at individual CpG sites generated from dorsolateral prefrontal cortex tissue using a bead assay. MAIN OUTCOMES AND MEASURES Pathological diagnosis of AD by National Institute on Aging-Reagan criteria following a standard postmortem examination. RESULTS Overall, 447 participants (60.4%) met the criteria for pathological diagnosis of AD. Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 was associated with pathological AD. The association was robustly retained after replacing the binary trait of pathological AD with 2 quantitative and molecular specific hallmarks of AD, namely, Aβ load and paired helical filament tau tangle density. Furthermore, RNA expression of transcripts of SORL1 and ABCA7 was associated with paired helical filament tau tangle density, and the expression of BIN1 was associated with Aβ load. CONCLUSIONS AND RELEVANCE Brain DNA methylation in multiple AD loci is associated with AD pathologies. The results provide further evidence that disruption of DNA methylation is involved in the pathological process of AD.

[1]  J. Schneider,et al.  Overview and findings from the rush Memory and Aging Project. , 2012, Current Alzheimer research.

[2]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[3]  Y. Araki,et al.  RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway , 2003, Journal of Cell Science.

[4]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[5]  P. Hof,et al.  Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients , 2013, Neurobiology of Aging.

[6]  Peter Langfelder,et al.  Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects , 2012, BMC Genomics.

[7]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[8]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[9]  J. Schneider,et al.  Overview and findings from the religious orders study. , 2012, Current Alzheimer research.

[10]  D. Elliott,et al.  Deletion of Abca7 Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease , 2013, The Journal of Neuroscience.

[11]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.

[12]  Lijun Cheng,et al.  Genetic control of individual differences in gene-specific methylation in human brain. , 2010, American journal of human genetics.

[13]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[14]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[15]  Joseph Rogers,et al.  Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation , 2010, Neurobiology of Aging.

[16]  Manolis Kellis,et al.  Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .

[17]  J. Gilbert,et al.  Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians , 2013, Neurobiology of Aging.

[18]  S. Rapoport,et al.  Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients , 2012, Translational Psychiatry.

[19]  A. Hill,et al.  ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro , 2008, Journal of neurochemistry.

[20]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[21]  H. Kipen,et al.  Questions and Answers 1 , 1994 .

[22]  Pietro De Camilli,et al.  BAR, F-BAR (EFC) and ENTH/ANTH domains in the regulation of membrane-cytosol interfaces and membrane curvature. , 2006, Biochimica et biophysica acta.

[23]  R. Mayeux,et al.  C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. , 2013, JAMA neurology.

[24]  Howard Hu,et al.  Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. , 2012, Journal of Alzheimer's disease : JAD.

[25]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[26]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[27]  Thomas W. Mühleisen,et al.  Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2009, Nature Genetics.

[28]  D. Balding,et al.  Epigenome-wide association studies for common human diseases , 2011, Nature Reviews Genetics.

[29]  S. Love,et al.  BIN1 Is Decreased in Sporadic but Not Familial Alzheimer’s Disease or in Aging , 2013, PloS one.

[30]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[31]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[32]  Kunlin Chen,et al.  The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. , 2009, Biochemical and biophysical research communications.

[33]  J. Mill,et al.  SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer’s Disease , 2012, Neurochemistry International.

[34]  A. McRae,et al.  GWAS findings for human iris patterns: associations with variants in genes that influence normal neuronal pattern development. , 2011, American journal of human genetics.

[35]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[36]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  M. Daly,et al.  Variant TREM2 as risk factor for Alzheimer's disease. , 2013, The New England journal of medicine.

[38]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[39]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[40]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[41]  S. Leurgans,et al.  Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. , 2011, Journal of Alzheimer's disease : JAD.

[42]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[43]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[44]  M. Owen,et al.  Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.

[45]  Nick C Fox,et al.  Common variants at ABCA 7 , MS 4 A 6 A / MS 4 A 4 E , EPHA 1 , CD 33 and CD 2 AP are associated with Alzheimer ’ s disease , 2011 .

[46]  Hong Qing,et al.  DNA methylation, a hand behind neurodegenerative diseases , 2013, Front. Aging Neurosci..

[47]  Luigi Ferrucci,et al.  Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain , 2010, PLoS genetics.

[48]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[49]  A. Singleton,et al.  TREM2 Variants in Alz hei mer's Disease , 2012 .

[50]  Klaus-Peter Lesch,et al.  Epigenetically regulated microRNAs in Alzheimer's disease , 2014, Neurobiology of Aging.